SATISFYER_1170x120_8-13-20

SARS-CoV-2 in vitro diagnostic assays

Nimble teams to discover and develop novel peptide-based compounds for SARS-CoV-2 diagnostics

Nimble teams to discover and develop novel peptide-based compounds for SARS-CoV-2 diagnostics

MADISON, Wis. — Nimble Therapeutics announced a collaboration with Roche Diagnostics to accelerate discovery of novel peptide-based molecules for the development of SARS-CoV-2 in vitro diagnostic assays. Nimble will extend its proprietary peptide synthesis, screening and optimization platform to enable faster discovery and optimization of promising compounds for detecting SARS-CoV-2. Roche will leverage its world-class